| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/2014 | CN103596582A Pharmaceutical composition |
| 02/19/2014 | CN103596580A Lyophilized preparation of botulinum toxin |
| 02/19/2014 | CN103596570A Oxidosqualene cyclase as a protein target for anticancer therapeutics |
| 02/19/2014 | CN103596553A System and method for multiphasic release of growth factors |
| 02/19/2014 | CN103596442A Novel application of reduced-fat soybean protein material to soybean-derived raw material-containing food or beverage |
| 02/19/2014 | CN103589784A Micro-RNA-based method and composition for the diagnosis and treatment of colon cancer-related diseases |
| 02/19/2014 | CN103589692A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 02/19/2014 | CN103588861A New Delhi metallo-beta-lactamase inhibitory peptide and application thereof |
| 02/19/2014 | CN103588859A Centipede active peptide and application thereof in pharmacy |
| 02/19/2014 | CN103585635A Slow-release polylactic acid microsphere capable of maintaining protein and polypeptide drug activity and preparation method thereof |
| 02/19/2014 | CN103585633A Freeze-drying protective agent for recombinant porcine interferon alpha 1 and preparation method thereof |
| 02/19/2014 | CN103585631A Method for preventing and treating tumors by using microRNA sponge technology |
| 02/19/2014 | CN103585629A New target for preventing and treating insulin resistance and its related diseases |
| 02/19/2014 | CN103585621A Treatment of a alpha-galactosidase a deficiency |
| 02/19/2014 | CN103585620A Application of irisin to preparation of drugs for preventing myocardial ischemia-reperfusion injury |
| 02/19/2014 | CN103585619A Application of DJ-1 protein in preparation of product for diagnosis and therapy of osteosarcoma |
| 02/19/2014 | CN103585618A Application of death-domain associated protein (DAXX) in preparation of tumor cell regulation agent |
| 02/19/2014 | CN103585617A Compounded anti-chicken escherichia coli veterinary medicine preparation |
| 02/19/2014 | CN103585616A Use of dipeptide analogue |
| 02/19/2014 | CN103585522A Veterinary drug for treating pullorum disease |
| 02/19/2014 | CN103585177A Applications of mesenchymal stem cell and genetically modified mesenchymal stem cell |
| 02/19/2014 | CN103585118A Freeze-drying method of recombinant porcine interferon alpha 1 (rPoIFN alpha 1) product |
| 02/19/2014 | CN103585114A Improved method for preparing exenatide sustained release microspheres |
| 02/19/2014 | CN103583955A Calcium supplementing composition |
| 02/19/2014 | CN103059123B Recombinant porcine interferon beta1, encoding gene and expression method thereof |
| 02/19/2014 | CN102813941B Application of growth factor gene drug in preventing and treating stress-related gastrointestinal injury |
| 02/19/2014 | CN102807609B Polypeptide for preventing and/or treating pain and application of polypeptide |
| 02/19/2014 | CN102784382B Argatroban drug composition and preparation method and application of argatroban drug composition |
| 02/19/2014 | CN102727874B Recombinant hirudin eye drops and preparation method thereof |
| 02/19/2014 | CN102552883B Polypeptide compound, pharmaceutical composition, its preparation method and application thereof |
| 02/19/2014 | CN102286586B Method for preparing oligopeptide of snake meat |
| 02/19/2014 | CN102276726B Fusion protein of hepatocyte growth factor receptor active group |
| 02/19/2014 | CN101842026B Bone-strengthening food material |
| 02/19/2014 | CN101796069B Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats |
| 02/19/2014 | CN101791395B Application of phospholipid scramblase 1 in preparing anti-hepatitis B virus infective medicament |
| 02/19/2014 | CN101273059B Alpha-MSH analogue of therapeutic activity |
| 02/18/2014 | US8653252 Short interfering RNA (siRNA) analogues |
| 02/18/2014 | US8653240 Thiosulfonate compound, reversible cationization agent for protein and/or peptide, and method for solubilization |
| 02/18/2014 | US8653239 Method for isolating polypeptides |
| 02/18/2014 | US8653237 Peptide analogues |
| 02/18/2014 | US8653236 Therapeutic agents |
| 02/18/2014 | US8653235 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 02/18/2014 | US8653233 Compositions and methods for preventing or treating cancer |
| 02/18/2014 | US8653117 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof |
| 02/18/2014 | US8653039 Peptide based inhibition of caPCNA interaction in cancer |
| 02/18/2014 | US8653038 HLA-A* 1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 02/18/2014 | US8653037 Proteins that fluoresce at infrared wavelengths or generate singlet oxygen upon illumination |
| 02/18/2014 | US8653036 Methods of treating retinitis pigmentosa |
| 02/18/2014 | US8653035 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| 02/18/2014 | US8653034 Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives |
| 02/18/2014 | US8653033 Method for administering omega-conopeptide |
| 02/18/2014 | US8653032 Pharmaceutical composition for preventing / treating TRPV1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient |
| 02/18/2014 | US8653031 Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin—(1-7) |
| 02/18/2014 | US8653030 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 02/18/2014 | US8653029 Flowable paste and putty bone void filler |
| 02/18/2014 | US8653028 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 02/18/2014 | US8653027 Method of treatment of type-1 diabetes with humanin analogues |
| 02/18/2014 | US8653025 Polyheterocyclic compounds highly potent as HCV inhibitors |
| 02/18/2014 | US8653024 Use of AMPs for treatment of UTI/cystitis |
| 02/18/2014 | US8653022 Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia |
| 02/18/2014 | US8652841 Culture methods of bone marrow stromal cells and mesenchymal stem cells, and manufacture method of graft cells for central nerve system diseases therapy |
| 02/18/2014 | US8652806 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection |
| 02/18/2014 | US8652797 Methods of NAD-dependent deacetylation of a lysine residue in a protein |
| 02/18/2014 | US8652530 Preservation of the biological activity of undenatured type II collagen |
| 02/18/2014 | US8652526 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 02/18/2014 | US8652524 Organ regeneration device |
| 02/18/2014 | US8652518 Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation |
| 02/18/2014 | US8652514 Antimicrobial peptides |
| 02/18/2014 | US8652489 Therapeutic composition with a botulinum neurotoxin |
| 02/18/2014 | US8652486 Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications |
| 02/18/2014 | US8652485 Peptide for vaccine |
| 02/18/2014 | US8652484 Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| 02/18/2014 | US8652479 Antibody-drug conjugates and methods |
| 02/18/2014 | US8652476 Pharmaceutical composition for treating ischemic events |
| 02/18/2014 | US8652464 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
| 02/18/2014 | US8652463 Dietary supplement to reduce the occurrence of migraines and treat their symptoms |
| 02/18/2014 | US8652457 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection |
| 02/18/2014 | CA2688574C Cyclic peptide cxcr4 antagonists |
| 02/18/2014 | CA2633468C Novel neurotrophic factor protein and uses thereof |
| 02/18/2014 | CA2589553C Use of flagellin in the immunotherapy of yersinia pestis |
| 02/18/2014 | CA2588594C Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 02/18/2014 | CA2577183C Mutated hiv nef for modulating immunity |
| 02/18/2014 | CA2567495C Methods for treating bleeding disorders using sulfated polysaccharides |
| 02/18/2014 | CA2548310C Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 02/18/2014 | CA2544820C Bacterial expression of protease inhibitors and variants thereof |
| 02/18/2014 | CA2544467C Paralytic peptide for use in neuromuscular therapy |
| 02/18/2014 | CA2500742C Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis |
| 02/18/2014 | CA2496317C Method of producing hydroxyalkyl starch derivatives |
| 02/18/2014 | CA2472203C The use of il6r/il6 chimera in nerve cell regeneration |
| 02/18/2014 | CA2471857C Microbially-expressed thermotolerant phytase for animal feed |
| 02/18/2014 | CA2454756C Methods and compounds for the targeting of protein to exosomes |
| 02/18/2014 | CA2451741C Peyers's patch and/or m-celle targeting ligands |
| 02/18/2014 | CA2429814C Rna interference mediating small rna molecules |
| 02/18/2014 | CA2403486C Talaromyces emersonii beta-glucanases |
| 02/18/2014 | CA2403313C Potent t cell modulating molecules |
| 02/18/2014 | CA2331923C Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 02/13/2014 | WO2014026163A2 Contact lens use in the treatment of an ophthalmologic condition |
| 02/13/2014 | WO2014026142A1 Methods and compostions for tissue adhesives |
| 02/13/2014 | WO2014026140A1 Methods for diagnosing, prognosing and treating muscular dystrophy |
| 02/13/2014 | WO2014026121A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |